In 2018, there will be an estimated 1,735,350 new cancer cases diagnosed and 609,640 cancer deaths in the United States alone. (cancer.org)
Unfortunately, we ALL know people who have been diagnosed with cancer, and/or have passed away from cancer. For many, cancer seems a random and unavoidable nightmare.
In addition, general cancer screening isn’t promoted or taken advantage of nearly enough. Unfortunately, the physicians who do encourage their patients to participate in Hereditary Cancer Predisposition Testing are often utilizing clinical laboratories that test for a minimal number of gene-markers, which often miss the mark, and don’t provide patients with enough relevant clinical data to make an adequate determination.
The Health Awareness Project’s CGx panels which test for an industry
leading 33-gene markers, which allow the provider and patient
to understand if they are predisposed to acquiring other cancer(s).
Patients who qualify for the test include:
Additionally, there are some insurance providers who still cover this test if the patient does not personally have cancer. In these instances, it is required that the patient has 1st or 2nd degree relatives with a history of cancer. Deeming the test as a medical necessity. Taking the test allows the patient to be proactive and learn as early as possible what changes need to be made if they are more pre-disposed to acquiring one or more cancer(s). Taking advantage of this revolutionary test can save millions of lives. Providers who encourage patients to take the CGx test are providing a true difference for countless families.